Shame can shape how early patients get diagnosed, and how aggressively they pursue treatment, if at all. In a 2014 study, Dr. Carter-Bawa found that lung cancer stigma was tied to patients waiting longer to seek care, regardless of smoking status or health care distrust.

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to his lungs and brain, leaving him in constant pain and unable to walk.

A 69-year-old Greeley woman had just hiked 8 miles in Sedona, Arizona, when she received a call that she had lung cancer. Despite her active lifestyle, a past of smoking crept up on her without any warning signs. Known as a “silent killer,” lung cancer ...

Those in the Augusta community have the opportunity to participant in an educational meeting about lung cancer on Tuesday.

Lung cancer stigma stems from its association with smoking, affecting patients' emotional well-being and support systems. Stigmatization can lead to increased distress, isolation, and a lack of support, impacting patients' quality of life.

For November's Lung Cancer Awareness Month, survivor Dusty Donaldson, 71, has been meeting with patients, researchers and fellow advocates across the country LiveLung Dusty Donaldson, a lung cancer survivor, set out on a 12,000-mile road trip to raise ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases a person’s risk of developing lung cancer. Additionally, when these two diseases overlap,

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

Shares of ImmunityBio (NASDAQ:IBRX) climbed 6% on Wednesday morning after the company said Saudi Arabia’s Food and Drug Authority had granted accelerated approval for its ANKTIVA treatment, to be used alongside checkpoint inhibitors in patients with metastatic non-small cell lung cancer.